BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 38626520)

  • 1. Klotho Stabilizes the Podocyte Actin Cytoskeleton in Idiopathic Membranous Nephropathy through Regulating the TRPC6/CatL Pathway.
    Wang H; Liu H; Cheng H; Xue X; Ge Y; Wang X; Yuan J
    Am J Nephrol; 2024; 55(3):345-360. PubMed ID: 38330925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy.
    Gu L; Dai Y; Xu J; Mallipattu S; Kaufman L; Klotman PE; He JC; Chuang PY
    AIDS; 2013 Apr; 27(7):1091-8. PubMed ID: 23343908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating metabolomics and network pharmacology to assess the effects of Mahuang Xixin Fuzi decoction on migraine rats induced by nitroglycerin.
    Ge F; Zhang Y; Luo Y; Wang C; Lu Y; Zhao Y; Zhang D; Meng F; Zhang D; Chen M; Tao X
    J Pharm Pharmacol; 2024 Jun; 76(6):710-723. PubMed ID: 38517943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podocyte Pathogenic Bone Morphogenetic Protein-2 Pathway and Immune Cell Behaviors in Primary Membranous Nephropathy.
    Cai A; Meng Y; Zhou H; Cai H; Shao X; Wang Q; Xu Y; Zhou Y; Zhou W; Chen L; Mou S
    Adv Sci (Weinh); 2024 May; ():e2404151. PubMed ID: 38785168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ameliorative Effect of Mahuang Fuzi and Shenzhuo Decoction on Membranous Nephropathy of Rodent Model is Associated With Autophagy and Wnt/β-Catenin Pathway.
    Gao Y; Dai H; Zhang N; Jiang H; Zhang Z; Feng Z; Dong Z; Liu W; Liu F; Dong X; Zhao Q; Zhou X; Du J; Zhang N; Rui H; Liu B
    Front Pharmacol; 2022; 13():820130. PubMed ID: 35529432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of Mahuang Fuzi and Shenzhuo Decoction for treatment of primary membranous nephropathy: a multicenter prospective trial.
    Zhang N; Jiang H; Dai H; Huang S; Zhao Q; Zhang N; Liu W; Dong Z; Gao Y; Dong X; Hu Y; Hou F; Rui H; Liu Q; Liu B
    Ren Fail; 2024 Dec; 46(1):2320834. PubMed ID: 38482580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alleviation by Mahuang Fuzi and Shenzhuo Decoction in High Glucose-Induced Podocyte Injury by Inhibiting the Activation of Wnt/
    Dai H; Liu F; Qiu X; Liu W; Dong Z; Jia Y; Feng Z; Liu Z; Zhao Q; Gao Y; Zhang Z; Gao C; Sun S; Tian X; Liu B
    Evid Based Complement Alternat Med; 2020; 2020():7809427. PubMed ID: 32963573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin Improves the Renal Autophagy in Rat Experimental Membranous Nephropathy via Regulating the PI3K/AKT/mTOR and Nrf2/HO-1 Signaling Pathways.
    Di Tu Q; Jin J; Hu X; Ren Y; Zhao L; He Q
    Biomed Res Int; 2020; 2020():7069052. PubMed ID: 33204708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4.
    Peng L; Ma J; Cui R; Chen X; Wei SY; Wei QJ; Li B
    PLoS One; 2014; 9(8):e106164. PubMed ID: 25165975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction (MFSD) to repair podocyte damage.
    Zhao Q; Dai H; Jiang H; Zhang N; Hou F; Zheng Y; Gao Y; Liu W; Feng Z; Hu Y; Tang X; Rui H; Liu B
    Biomed Pharmacother; 2024 May; 174():116583. PubMed ID: 38626520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men.
    Ronco P; Debiec H
    Semin Immunopathol; 2007 Nov; 29(4):445-58. PubMed ID: 17899086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A podocyte view of membranous nephropathy: from Heymann nephritis to the childhood human disease.
    Ronco P; Debiec H
    Pflugers Arch; 2017 Aug; 469(7-8):997-1005. PubMed ID: 28597189
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.